Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer.
Takada R, Ikezawa K, Yamai T, Watsuji K, Seiki Y, Kawamoto Y, Hirao T, Higashi S, Urabe M, Kai Y, Nakabori T, Uehara H, Kotani M, Yagi T, Kimura M, Nozaki K, Takagi M, Ohkawa K.
Takada R, et al. Among authors: uehara h.
BMC Cancer. 2023 Jul 31;23(1):711. doi: 10.1186/s12885-023-11205-6.
BMC Cancer. 2023.
PMID: 37518012
Free PMC article.